Page 2 - Pacira Biosciences Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pacira BioSciences (PCRX) Buy Rating Reaffirmed at HC Wainwright

Pacira BioSciences (PCRX) Buy Rating Reaffirmed at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesPacira biosciences incNeedham companyChina universal asset management coCape investment advisory incRoyal bankSecurities exchange commissionQuadrant capital groupNisa investment advisorsGroup wealth managementGet free reportDirector garyExchange commissionWealth managementUniversal asset management

Analysts Set Pacira BioSciences, Inc (NASDAQ:PCRX) PT at $49 50

Analysts Set Pacira BioSciences, Inc (NASDAQ:PCRX) PT at $49 50
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesMitsubishi ufjNeedham companyChina universal asset management coKokusai asset management coJp morgan private wealth advisorsPacira biosciences company profilePacira biosciences incIllinois municipal retirement fundRoyal bankGet free reportDirector garyAsset managementUniversal asset managementPrivate wealth advisors

Pacira BioSciences, Inc (NASDAQ:PCRX) Given Average Rating of Buy by Brokerages

Pacira BioSciences, Inc (NASDAQ:PCRX) Given Average Rating of Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesMitsubishi ufjNeedham companyChina universal asset management coKokusai asset management coJp morgan private wealth advisorsPacira biosciences company profileJpmorgan chase coPacira biosciences incSecurities exchange commissionIllinois municipal retirement fundRoyal bankGet free reportMarketbeat ratingsBiosciences trading down

Duality Advisers LP Boosts Stock Position in Pacira BioSciences, Inc (NASDAQ:PCRX)

Duality Advisers LP Boosts Stock Position in Pacira BioSciences, Inc (NASDAQ:PCRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesAllspring global investments holdingsMitsubishi ufjCampbell co investment adviserJpmorgan chase coPacira biosciences incRoyal bankNisa investment advisorsKokusai asset management coPacira biosciences company profileSecurities exchange commissionChina universal asset management coDuality advisersFree reportUniversal asset management

Pacira BioSciences (NASDAQ:PCRX) Hits New 12-Month Low at $25 74

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $25.74 and last traded at $25.76, with a volume of 63285 shares changing hands. The stock had previously closed at $26.25. Analyst Upgrades and Downgrades A number of equities research analysts have commented […]

United statesPacira biosciencesChina universal asset management coJpmorgan chase coCape investment advisory incPacira biosciences incRoyal bankQuadrant capital groupNisa investment advisorsGroup wealth managementSecurities exchange commissionNeedham companyGet free reportDirector garyExchange commissionWealth management